Frequency, causes, and new challenges of indeterminate results in western blot confirmatory testing for antibodies to human immunodeficiency virus

Clinical and Vaccine Immunology

Volumn 14, Issue 6, 2007, Pages 649-659

  Guan, Ming ^a  

^a MP Biomedicals Asia Pacific Pte Ltd   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTIGEN P24; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALGORITHM; BLOOD DONOR; DIAGNOSTIC ERROR; DIAGNOSTIC KIT; DIFFERENTIAL DIAGNOSIS; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FREQUENCY ANALYSIS; HEALTH CENTER; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS 2 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOASSAY; PREGNANT WOMAN; PRIORITY JOURNAL; RETROVIRUS; SCREENING TEST; SHORT SURVEY; VIRION; WESTERN BLOTTING;

BLOTTING, WESTERN; FALSE POSITIVE REACTIONS; HIV; HIV ANTIBODIES; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; REAGENT KITS, DIAGNOSTIC; SENSITIVITY AND SPECIFICITY;

EID: 34547113746     PISSN: 15566811     EISSN: None     Source Type: Journal    
DOI: 10.1128/CVI.00393-06     Document Type: Short Survey

References (107)

1. Alter, H. J., J. S. Epstein, S. G. Swenson, M. J. VanRaden, J. W. Ward, R. A. Kaslow, J. E. Menitove, H. G. Klein, S. G. Sandler, M. H. Sayers, et al. 1990. Prevalence of human immunodeficiency virus type 1 p24 antigen in U.S. blood donors - an assessment of the efficacy of testing in donor screening. N. Engl. J. Med. 323:1312-1317.
2. Barthel, H. R., and D. J. Wallace. 1993. False-positive human immunodeficiency virus testing in patients with lupus erythematosus. Semin. Arthritis Rheum. 23:1-7.
3. Baskar, P. V., G. D. Collins, B. A. Dorsey-Cooper, R. S. Pyle, J. E. Nagel, D. Dwyer, G. Dunston, C. E. Johnson, N. Kendig, E. Israel, D. R. Nalin, and W. H. Adler. 1998. Serum antibodies to HIV-1 are produced post-measles virus infection: evidence for cross-reactivity with HLA. Clin. Exp. Immunol. 111:251-256.
4. Bassetti-Soares, E., C. A. Andrade, M. V. Lima-Martins, A M. de Pinho, E. Barezani, and A. B. Carneiro-Proietti. 2001. Inconclusive HIV-1/2 results: how far should blood centers go? Braz. J. Infect. Dis. 5:161-162.
5. Behets, F., A. Disasi, R. W. Ryder, K. Bishagara, P. Piot, M. Kashamuka, M. Kamenga, N. Nzila, M. Laga, G. Vercauteren, V. Batter, C. Brown, and T. Quinn. 1991. Comparison of five commercial enzyme-linked immunosorbent assays and Western immunoblotting for human immunodeficiency virus antibody detection in serum samples from Central Africa. J. Clin. Microbiol. 29:2280-2284.
6. Biggar, R. J., M. Melbye, P. Ebbesen, S. Alexander, J. O. Nielsen, P. Sarin, and V. Faber. 1985. Variation in human T lymphotropic virus III (HTLV-III) antibodies in homosexual men: decline before onset of illness related to acquired immune deficiency syndrome (AIDS). Br. Med. J. 291:997-998.
7. Blomberg, J., and P. J. Klasse. 1988. Specificities and sensitivities of three systems for determination of antibodies to human immunodeficiency virus by electrophoretic immunoblotting. J. Clin. Microbiol. 26:106-110.
8. Brust, S., H. Duttmann, J. Feldner, L. Gurtler, R. Thorstensson, and F. Simon. 2000. Shortening of the diagnostic window with a new combined HIV p24 antigen and anti-HIV-1/2/O screening test. J. Virol. Methods 90:153-165.
9. Busch, M. P., and G. A. Satten. 1997. Time course of viremia and antibody seroconversion following human immunodeficiency virus exposure. Am. J. Med. 102:117-124.
10. Carneiro-Proietti, A. B., I. W. Cunha, M. M. Souza, D. R. Oliveira, N. M. Mesquita, C. A. Andrade, B. C. Catalan-Soares, M. V. Lima-Martins, and F. A. Proietti. 1999. HIV-(1/2) indeterminate Western blot results: follow-up of asymptomatic blood donors in Belo Horizonte, Minas Gerais, Brazil. Rev. Inst. Med. Trop. Sao Paulo 41:155-158.
11. Caselli, D., A. Maccabruni, A. Deicas, G. Bossi, M. Degioanni, G. Achilli, and M. Arico. 1993. Indeterminate Western blot in children who serorevert for HIV. Ann. N. Y. Acad. Sci. 693:275-276.
12. Celum, C. L., R. W. Coombs, M. Jones, V. Murphy, L. Fisher, C. Grant, L. Corey, T. Inui, M. H. Wener, and K. K. Holmes. 1994. Risk factors for repeatedly reactive HIV-1 EIA and indeterminate Western blots. A population-based case-control study. Arch. Intern. Med. 154:1129-1137.
13. Celum, C. L., R. W. Coombs, W. Lafferty, T. S. Inui, P. H. Louie, C. A. Gates, B. J. McCreedy, R. Egan, T. Grove, and S. Alexander. 1991. Indeterminate human immunodeficiency virus type 1 Western blots: seroconversion risk, specificity of supplemental tests, and an algorithm for evaluation. J. Infect. Dis. 164:656-664.
14. Centers for Disease Control and Prevention. 1987. Perspectives in disease prevention and health promotion public health service guidelines for counseling and antibody testing to prevent HIV infection and AIDS. Morb. Mortal. Wkly. Rep. 36:509-515.
15. Centers for Disease Control and Prevention. 1989. Interpretation and use of the Western blot assay for serodiagnosis of human immunodeficiency virus type 1 infection. Morb. Mortal. Wkly. Rep. 38(S-7):1-7.
16. Centers for Disease Control and Prevention. 1989. Problems created by heat-inactivation of serum specimens before HIV-1 antibody testing. Morb. Mortal. Wkly. Rep. 38:407-408.
17. Centers for Disease Control and Prevention. 2001. Revised guidelines for HIV counseling, testing, and referral and revised recommendations for HIV screening of pregnant women - United States. Morb. Mortal. Wkly. Rep. 50(RR-19):1-57, 63-85.
18. Centers for Disease Control and Prevention. 2006. Provisional procedureal guidance for community-based organizations. U.S. Department of Health and Human Services, Atlanta, GA.
19. Clark, J. L., T. J. Coates, A. G. Lescano, R. Castillo, R. Meza, F. R. Jones, S. Leon, J. Pajuelo, C. F. Caceres, and J. D. Klausner. 2006. Different positive predictive values of commercially available human immunodeficiency virus enzyme-linked immunosorbent assays. Clin. Vaccine Immunol. 13:302-303.
20. Constantine, N. T., and H. Zink. 2005. HIV testing technologies after two decades of evolution. Indian J. Med. Res. 121:519-538.
21. Cremonezi, D., P. E. Mesquita, M. M. Romao, and L. E. Prestes-Carneiro. 2005. Prevalence of indeterminate human immunodeficiency virus Western blot results in pregnant women attended at a public hospital in Presidente Prudente, Brazil. Braz J. Infect. Dis. 9:506-509.
22. Daar, E. S., S. Little, J. Pitt, J. Santangelo, P. Ho, N. Harawa, P. Kerndt, J. V. Giorgi, J. Bai, P. Gaut, D. D. Richman, S. Mandel, and S. Nichols. 2001. Diagnosis of primary HIV-1 infection. Ann. Intern. Med. 134:25-29.
23. Dax, E. M., and A. Arnott. 2004. Advances in laboratory testing for HIV. Pathology 36:551-560.
24. De Baets, A. J., B. S. Edidi, M. J. Kasali, G. Beelaert, W. Schrooten, A. Litzroth, P. Kolsteren, D. Denolf, and K. Fransen. 2005. Pediatric human immunodeficiency virus screening in an African district hospital. Clin. Diagn. Lab. Immunol. 12:86-92.
25. Dock, N. L., H. V. Lamberson, Jr., T. A. O'Brien, D. E. Tribe, S. S. Alexander, and B. J. Poiesz. 1988. Evaluation of atypical human immunodeficiency virus immunoblot reactivity in blood donors. Transfusion 28:412-418.
26. Dock, N. L., S. H. Kleinman, M. A. Rayfield, C. A. Schable, A. E. Williams, and R. Y. Dodd. 1991. Human immunodeficiency virus infection and indeterminate Western blot patterns. Prospective studies in a low prevalence population. Arch. Intern. Med. 151:525-530.
27. Dodd, R. Y., and S. L. Stramer. 2000. Indeterminate results in blood donor testing: what you don't know can hurt you. Transfus. Med. Rev. 14:151-160.
28. Elemuwa, C. O., B. E. Bassey, and D. O. Olaleye. 2005. The problems of indeterminate HIV results in blood transfusion services in Nigeria. Trop. Doct. 35:166-167.
29. Fiebig, E. W., D. J. Wright, B. D. Rawal, P. E. Garrett, R. T. Schumacher, L. Peddada, C. Heldebrant, R. Smith, A. Conrad, S. H. Kleinman, and M. P. Busch. 2003. Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS 17:1871-1879.
30. Genesca, J., J. W. Shih, B. W. Jett, I. K. Hewlett, J. S. Epstein, and H. J. Alter. 1989. What do Western blot indeterminate patterns for human immunodeficiency virus mean in EIA-negative blood donors? Lancet 28:1023-1025.
31. Georgoulias, V. A., N. E. Malliaraki, M. Theodoropoulou, E. Spanakis, P. Fountouli, D. Tsatsaki, S. Kotsaki, A. Karvela-Aggelaki, and E. Malliaraki-Pinetidou. 1997. Indeterminate human immunodeficiency virus type 1 Western blot may indicate an abortive infection in some low-risk blood donors. Transfusion 37:65-72.
32. Goldfarb, M. F. 1988. Effect of heat inactivation on results of HIV antibody detection by Western blot assay. Clin. Chem. 34:1661-1662.
33. Granade, T. C., B. S. Parekh, P. M. Tih, T. Welty, E. Welty, M. Bulterys, G. Ndikintum, G. Nkuoh, and S. Tancho. 2005. Evaluation of rapid prenatal human immunodeficiency virus testing in rural Cameroon. Clin. Diagn. Lab. Immunol. 12:855-860.
34. Gurtler, L., A. Muhlbacher, U. Michl, H. Hofmann, G. G. Paggi, V. Bossi, R. Thorstensson, R. G. Villaescusa, A. Eiras, J. M. Hernandez, W. Melchior, F. Donie, and B. Weber. 1998. Reduction of the diagnostic window with a new combined p24 antigen and human immunodeficiency virus antibody screening assay. J. Virol. Methods 75:27-38.
35. Hart, D. J., R. G. Heath, F. J. Sautter, Jr., B. D. Schwartz, R. F. Garry, B. Choi, M. A. Beilke, and L. K. Hart. 1999. Antiretroviral antibodies: implications for schizophrenia, schizophrenia spectrum disorders, and bipolar disorder. Biol. Psychiatry 45:704-714.
36. Huang, L. J., C. Y. Liu, S. C. Chu, W. W. Wong, Y. C. Lin, W. T. Liu, and Y. J. Chan. 2006. Predictive value of two commercial human immunodeficiency virus serological tests in cases with indeterminate Western blot results. J. Microbiol. Immunol. Infect. 39:219-224.
37. Jackson, J. B., K. L. MacDonald, J. Cadwell, C. Sullivan, W. E. Kline, M. Hanson, K. J. Sannerud, S. L. Stramer, N. J. Fildes, and S. Y. Kwok. 1990. Absence of HIV infection in blood donors with indeterminate Western blot tests for antibody to HIV-1. N. Engl. J. Med. 322:217-222.
38. Jackson, J. B., M. R. Hanson, G. M. Johnson, T. G. Spahlinger, H. F. Polesky, and R. J. Bowman. 1995. Long-term follow-up of blood donors with indeterminate human immunodeficiency virus type 1 results on Western blot. Transfusion 35:98-102.
39. Jamjoom, G. A., J. Maatouk, M. Gazal, L. Damanhouri, A. Awliaa, N. Ruwaihi, M. Bawazeer, H. Halabi, A. A. Adel, and A. Abdulla. 1997. Follow-up of HIV Western blot indeterminate results. Ann. Saudi Med. 17:518-521.
40. Janvier, B., A. Baillou, P. Archinard, M. Mounier, B. Mandrand, A. Goudeau, and F. Barin. 1991. Immune response to a major epitope of p24 during infection with human immunodeficiency virus type 1 and implications for diagnosis and prognosis. J. Clin. Microbiol. 29:488-492.
41. Josephson, S. L., N. S. Swack, M. T. Ramirez, and W. J. Hausler, Jr. 1989. Investigation of atypical Western blot (immunoblot) reactivity involving core proteins of human immunodeficiency virus type 1. J. Clin. Microbiol. 27:932-937.
42. Jungkind, D. L., S. A. DiRenzo, and S. J. Young. 1986. Effect of using heat-inactivated serum with the Abbott human T-cell lymphotropic virus type III antibody test. J. Clin. Microbiol. 23:381-382.
43. Kammerer, R., P. Burgisser, and P. C. Frei. 1995. Anti-human immunodeficiency virus type 1 antibodies of noninfected subjects are not related to autoantibodies occurring in systemic diseases. Clin. Diagn. Lab. Immunol. 2:458-461.
44. Kashala, O., R. Marlink, M. Ilunga, M. Diese, B. Gormus, K. Xu, P. Mukeba, K. Kasongo, and M. Essex. 1994. Infection with human immunodeficiency virus type 1 (HIV-1) and human T cell lymphotropic viruses among leprosy patients and contacts: correlation between HIV-1 cross-reactivity and antibodies to lipoarabinomannan. J. Infect. Dis. 169:296-304.
45. Kleinman, S., M. P. Busch, L. Hall, R. Thomson, S. Glynn, D. Gallahan, H. E. Ownby, and A. E. Williams. 1998. False-positive HIV-1 test results in a low-risk screening setting of voluntary blood donation. Retrovirus Epidemiology Donor Study. JAMA 280:1080-1085.
46. Kopko, P., L. Calhoun, and L. Petz. 1999. Distinguishing immunosilent AIDS from the acute retroviral syndrome in a frequent blood donor. Transfusion 39:383-386.
47. Kulshreshtha, R., A. Mathur, D. Chattopadhya, and U. C. Chaturvedi. 1996. HIV-2 prevalence in Uttar Pradesh. Indian J. Med. Res. 103:131-133.
48. Lai-Goldman, M., J. H. McBride, P. J. Howanitz, D. O. Rodgerson, J. A Miles, and J. B. Peter. 1987. Presence of HTLV-III antibodies in immune serum globulin preparations. Am. J. Clin. Pathol. 87:635-639.
49. Lai, R. B., D. Rudolph, M. P. Alpers, A. J. Sulzer, Y. P. Shi, and A. A Lal. 1994. Immunologic cross-reactivity between structural proteins of human T-cell lymphotropic virus type I and the blood stage of Plasmodium falciparum. Clin. Diagn. Lab. Immunol. 1:5-10.
50. Lange, J. M., D. A. Paul, H. G. Huisman, F. de Wolf, H. van den Berg, R. A. Coutinho, S. A. Danner, J. van der Noordaa, and J. Goudsmit. 1986. Persistent HIV antigenaemia and decline of HIV core antibodies associated with transition to AIDS. Br. Med. J. 293:1459-1462.
51. Ling, A. E., K. E. Robbins, T. M. Brown, V. Dunmire, S. Y. Thoe, S. Y. Wong, Y. S. Leo, D. Teo, J. Gallarda, B. Phelps, M. E. Chamberland, M. P. Busch, T. M. Folks, and M. L. Kalish. 2000. Failure of routine HIV-1 tests in a case involving transmission with preseroconversion blood components during the infectious window period. JAMA 284:210-214.
52. Ly, T. D., C. Edlinger, and A. Vabret. 2000. Contribution of combined detection assays of p24 antigen and anti-human immunodeficiency virus (HIV) antibodies in diagnosis of primary HIV infection by routine testing. J. Clin. Microbiol. 38:2459-2461.
53. Ly, T. D., L. Martin, D. Daghfal, A. Sandridge, D. West, R. Bristow, L. Chalouas, X. Qiu, S. C. Lou, J. C. Hunt, G. Schochetman, and S. G. Devare. 2001. Seven human immunodeficiency virus (HIV) antigen-antibody combination assays: evaluation of HIV seroconversion sensitivity and subtype detection. J. Clin. Microbiol. 39:3122-3128.
54. Mahe, C., P. Kaleebu, A. Ojwiya, and J. A. Whitworth. 2002. Human immunodeficiency virus type 1 Western blot: revised diagnostic criteria with fewer indeterminate results for epidemiological studies in Africa. Int. J. Epidemiol. 31:985-990.
55. McCutchan, F. E., M. Hoelscher, S. Tovanabutra, S. Piyasirisilp, E. Sanders-Buell, G. Ramos, L. Jagodzinski, V. Polonis, L. Maboko, D. Mmbando, O. Hoffmann, G. Riedner, F. von Sonnenburg, M. Robb, and D. L. Birx. 2005. In-depth analysis of a heterosexually acquired human immunodeficiency virus type 1 superinfection: evolution, temporal fluctuation, and intercompartment dynamics from the seronegative window period through 30 months postinfection. J. Virol. 79:11693-11704.
56. Meda, N., L. Gautier-Charpentier, R. B. Soudre, H. Dahourou, R. Ouedraogo-Traore, A. Ouangre, A. Bambara, A. Kpozehouen, H. Sanou, D. Valea, F. Ky, M. Cartoux, F. Barin, and P. Van de Perre. 1999. Serological diagnosis of human immuno-deficiency virus in Burkina Faso: reliable, practical strategies using less expensive commercial test kits. Bull. World Health Organ. 77:731-739.
57. Meles, H., D. Wolday, A. Fontanet, A. Tsegaye, T. Tilahun, M. Aklilu, E. Sanders, and T. F. De Wit. 2002. Indeterminate human immunodeficiency virus Western blot profiles in ethiopians with discordant screening-assay results. Clin. Diagn. Lab Immunol. 9:160-163.
58. Midthun, K., L. Garrison, M. L. Clements, H. Farzadegan, B. Fernie, T. Quinn, et al. 1990. Frequency of indeterminate Western blot tests in healthy adults at low risk for human immunodeficiency virus infection. J. Infect. Dis. 162:1379-1382.
59. Miles, S. A., E. Balden, L. Magpantay, L. Wei, A. Leiblein, D. Hofheinz, G. Toedter, E. R. Stiehm, Y. Bryson, et al. 1993. Rapid serologic testing with immune-complex-dissociated HIV p24 antigen for early detection of HIV infection in neonates. N. Engl. J. Med. 328:297-302.
60. Muller, Z., E. Stelzl, M. Bozic, J. Haas, E. Marth, and H. H. Kessler. 2004. Evaluation of automated sample preparation and quantitative PCR LCx assay for determination of human immunodeficiency virus type 1 RNA. J. Clin. Microbiol. 42:1439-1443.
61. Mylonakis, E., M. Paliou, and J. D. Rich. 2001. Plasma viral load testing in the management of HIV infection. Am. Fam. Physician 63:483-490.
62. Ngan, C. C., A. E. Ling, L. S. Lim, K. P. Chan, and J. E. Sng. 2001. Cutting out spurious gp160 bands from human immunodeficiency virus Western blot results. J. Clin. Microbiol. 39:411.
63. Ngan, C. C., S. Y. Thoe, K. P. Chan, J. E. Sng, and A. E. Ling. 2002. Alternative strategies for confirmation of human immunodeficiency virus infection require judicious use. J. Clin. Microbiol. 40:314-315.
64. Nuwayhid, N. F. 1995. Laboratory tests for detection of human immunodeficiency virus type 1 infection. Clin. Diagn. Lab. Immunol. 2:637-645.
65. Perrin, L. H., S. Yerly, N. Adami, P. Bachmann, E. Butler-Brunner, J. Burckhardt, and E. Kawashima. 1990. Human immunodeficiency virus DNA amplification and serology in blood donors. Blood 76:641-645.
66. Pilcher, C. D., S. A. Fiscus, T. Q. Nguyen, E. Foust, L. Wolf, D. Williams, R. Ashby, J. O. O'Dowd, J. T. McPherson, B. Stalzer, L. Hightow, W. C. Miller, J. J. Eron, Jr., M. S. Cohen, and P. A. Leone. 2005. Detection of acute infections during HIV testing in North Carolina. N. Engl. J. Med. 352:1873-1883.
67. Prince, H. E., and M. Gross. 2001. Impact of initial screening for human T-cell lymphotropic virus (HTLV) antibodies on efficiency of HTLV Western blotting. Clin. Diagn. Lab. Immunol. 8:467.
68. Ramirez, E., P. Uribe, D. Escanilla, G. Sanchez, and R. T. Espejo. 1992. Reactivity patterns and infection status of serum samples with indeterminate Western immunoblot tests for antibody to human immunodeficiency virus type 1. J. Clin. Microbiol. 30:801-805.
69. Rhodes, D., A. Solomon, W. Bolton, J. Wood, J. Sullivan, J. Learmont, and N. Deacon. 1999. Identification of a new recipient in the Sydney Blood Bank Cohort: a long-term HIV type 1-infected seroindeterminate individual. AIDS Res. Hum. Retrovir. 15:1433-1439.
70. Rich, J. D., N. A. Merriman, E. Mylonakis, T. C. Greenough, T. P. Flanigan, B. J. Mady, and C. C. Carpenter. 1999. Misdiagnosis of HIV infection by HIV-1 plasma viral load testing: a case series. Ann. Intern. Med. 130:37-39.
71. Rouet, F., D. K. Ekouevi, A. Inwoley, M. L. Chaix, M. Burgard, L. Bequet, I. Viho, V. Leroy, F. Simon, F. Dabis, and C. Rouzioux. 2004. Field evaluation of a rapid human immunodeficiency virus (HIV) serial serologic testing algorithm for diagnosis and differentiation of HIV type 1 (HIV-1), HIV-2, and dual HIV-1-HIV-2 infections in West African pregnant women. J. Clin. Microbiol. 42:4147-4153.
72. Roy, S., J. Portnoy, and M. A. Wainberg. 1987. Need for caution in interpretation of Western blot tests for HIV. JAMA 257:1047.
73. Roy, S., L. Fitz-Gibbon, B. Spira, J. Portnoy, and M. A. Wainberg. 1987. False-positive results of confirmatory testing for antibody to HIV-I. CMAJ 136:612-614.
74. Saah, A. J., H. Farzadegan, R. Fox, P. Nishanian, C. R. Rinaldo, Jr., J. P. Phair, J. L. Fahey, T. H. Lee, and B. F. Polk. 1987. Detection of early antibodies in human immunodeficiency virus infection by enzyme-linked immunosorbent assay, Western blot, and radioimmunoprecipitation. J. Clin. Microbiol. 25:1605-1610.
75. Santos, T. D., Jr., C. M. Costa, P. Goubau, A. M. Vandamme, J. Desmyter, S. Van Doren, R. M. Mota, F. B. de Castro Costa, A. C. Oliveira, V. Barreto, A. F. Gomes, A. B. Carneiro-Proietti, V. M. de Bruin, F. C. de Sousa, and R. B. Oria. 2003. Western blot seroindeterminate individuals for human T-lymphotropic virus I/II (HTLV-I/II) in Fortaleza (Brazil): a serological and molecular diagnostic and epidemiological approach. Braz. J. Infect. Dis. 7:202-209.
76. Saville, R. D., N. T. Constantine, F. R. Cleghorn, N. Jack, C. Bartholomew, J. Edwards, P. Gomez, and W. A Blattner. 2001. Fourth-generation enzyme-linked immunosorbent assay for the simultaneous detection of human immunodeficiency virus antigen and antibody. J. Clin. Microbiol. 39:2518-2524.
77. Schaefer, A., K. E. Robbins, E. N. Nzilambi, M. E. St Louis, T. C. Quinn, T. M. Folks, M. L. Kalish, and D. Pieniazek. 2005. Divergent HIV and simian immunodeficiency virus surveillance, Zaire. Emerg. Infect. Dis. 11:1446-1448.
78. Sethoe, S. Y., A. E. Ling, E. H. Sng, E. H. Monteiro, and R. K. Chan. 1995. PCR as a confirmatory test for human immunodeficiency virus type 1 infection in individuals with indeterminate Western blot (immunoblot) profiles. J. Clin. Microbiol. 33:3034-3036.
79. Shearer, W. T., T. C. Quinn, P. LaRussa, J. F. Lew, L. Mofenson, S. Almy, K. Rich, E. Handelsman, C. Diaz, M. Pagano, V. Smeriglio, L. A. Kalish, and the Women and Infants Transmission Study Group. 1997. Viral load and disease progression in infants infected with human immunodeficiency virus type 1. N. Engl. J. Med. 336:1337-1342.
80. Sherman, M. P., N. L. Dock, G. D. Ehrlich, J. J. Sninsky, C. Brothers, J. Gillsdorf, V. Bryz-Gornia, and B. J. Poiesz. 1995. Evaluation of HIV type 1 Western blot-indeterminate blood donors for the presence of human or bovine retroviruses. AIDS Res. Hum. Retrovir. 11:409-414.
81. Sickinger, E., M. Stieler, B. Kaufman, H. P. Kapprell, D. West, A. Sandridge, S. Devare, G. Schochetman, J. C. Hunt, D. Daghfal, and the AxSYM Clinical Study Group. 2004. Multicenter evaluation of a new, automated enzyme-linked immunoassay for detection of human immunodeficiency virus-specific antibodies and antigen. J. Clin. Microbiol. 42:21-29.
82. Singer, D. E., N. Kiwanuka, D. Serwadda, F. Nalugoda, L. Hird, J. Bulken-Hoover, G. Kigozi, J. A. Malia, E. K. Calero, W. Sateren, M. L. Robb, F. Wabwire-Mangen, M. Wawer, R. H. Gray, N. Sewankambo, D. L. Birx, and N. L. Michael. 2005. Use of stored serum from Uganda for development and evaluation of a human immunodeficiency virus type 1 testing algorithm involving multiple rapid immunoassays. J. Clin. Microbiol. 43:5312-5315.
83. Speers, D., P. Phillips, and J. Dyer. 2005. Combination assay detecting both human immunodeficiency virus (HIV) p24 antigen and anti-HIV antibodies opens a second diagnostic window. J. Clin. Microbiol. 43:5397-5399.
84. Stramer, S. L., S. A. Glynn, S. H. Kleinman, D. M. Strong, S. Caglioti, D. J. Wright, R. Y. Dodd, M. P. Busch, and the National Heart, Lung, and Blood Institute Nucleic Acid Test Study Group. 2004. Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing. N. Engl. J. Med. 351:760-768.
85. Sutthent, R., N. Gaudart, K. Chokpaibulkit, N. Tanliang, C. Kanoksinsombath, and P. Chaisilwatana. 2003. p24 antigen detection assay modified with a booster step for diagnosis and monitoring of human immunodeficiency virus type 1 infection. J. Clin. Microbiol. 41:1016-1022.
86. Swanson, P., C. de Mendoza, Y. Joshi, A. Golden, R. L. Hodinka, V. Soriano, S. G. Devare, and J. Hackett, Jr. 2005. Impact of human immunodeficiency virus type 1 (HIV-1) genetic diversity on performance of four commercial viral load assays: LCx HIV RNA Quantitative, AMPLICOR HIV-1 MONITOR v1.5, VERSANT HIV-1 RNA 3.0, and NucliSens HIV-1 QT. J. Clin. Microbiol. 43:3860-3868.
87. Syed Iqbal, H., P. Balakrishnan, S. S. Solomon, K. G. Murugavel, N. Kumarasamy, S. Vidya, S. P. Martin, S. P. Thyagarajan, K. H. Mayer, and S. Solomon. 2005. HIV-1 Western blot assay: What determines an indeterminate status? Indian J. Med. Sci. 59:443-450.
88. Talal, N., E. Flescher, and H. Dang. 1992. Are endogenous retroviruses involved in human autoimmune disease? J. Autoimmun. 5:61-66.
89. Talal, N., M. J. Dauphinee, H. Dang, S. S. Alexander, D. J. Hart, and R. F. Garry. 1990. Detection of serum antibodies to retroviral proteins in patients with primary Sjogren's syndrome (autoimmune exocrinopathy). Arthritis Rheum. 33:774-781.
90. Talal, N., R. F. Garry, P. H. Schur, S. Alexander, M. J. Dauphinee, I. H. Livas, A. Ballester, M. Takei, and H. A. Dang. 1990. Conserved idiotype and antibodies to retroviral proteins in systemic lupus erythematosus. J. Clin. Investig. 85:1866-1871.
91. Tesoro-Cruz, E., R. Hernandez-Gonzalez, R. Kretschmer-Schmid, and A. Aguilar-Setien. 2003. Cross-reactivity between caprine arthritis- encephalitis virus and type 1 human immunodeficiency virus. Arch. Med. Res. 34:362-366.
92. Thakral, B., K. Saluja, R. R. Sharma, and N. Marwaha. 2006. Algorithm for recall of HIV reactive Indian blood donors by sequential immunoassays enables selective donor referral for counseling. J. Postgrad. Med. 52:106-109.
93. Tsoukas, C. M., and N. F. Bernard. 1994. Markers predicting progression of human immunodeficiency virus-related disease. Clin. Microbiol. Rev. 7:14-28.
94. UNAIDS/WHO. 1998. The importance of simple/rapid assays in HIV testing. UNAIDS/WHO recommendations. Wkly. Epidemiol. Rec. 73:321-328.
95. UNAIDS/WHO Working Group on Global HIV/AIDS/STI Surveillance. 2001. Guidelines for using HIV technologies in surveillance: selection, evaluation, and implementation. World Health Organization, Geneva, Switzerland.
96. Urnovitz, H. B., J. C. Sturge, T. D. Gottfried, and W. H. Murphy. 1999. Urine antibody tests: new insights into the dynamics of HIV-1 infection. Clin. Chem. 45:1602-1613.
97. Urnovitz, H. B., and W. H. Murphy. 1996. Human endogenous retroviruses: nature, occurrence, and clinical implications in human disease. Clin. Microbiol. Rev. 9:72-99.
98. Vardinon, N., I. Yust, O. Katz, A. Iaina, Z. Katzir, D. Modai, and M. Burke. 1999. Anti-HIV indeterminate Western blot in dialysis patients: a long-term follow-up. Am. J. Kidney Dis. 34:146-149.
99. Wang, G. R., J. Y. Yang, T. L. Lin, H. Y. Chen, and C. B. Horng. 1997. Temperature effect on the sensitivity of ELISA, PA and WB to detect anti-HIV-1 antibody and infectivity of HIV-1. Zhonghua Yi Xue Za Zhi (Taipei) 59:325-333.
100. Weber, B., A. Berger, H. Rabenau, and H. W. Doerr. 2002. Evaluation of a new combined antigen and antibody human immunodeficiency virus screening assay, VIDAS HIV DUO Ultra. J. Clin. Microbiol. 40:1420-1426.
101. Weber, B., E. H. Fall, A. Berger, and H. W. Doerr. 1998. Reduction of diagnostic window by new fourth-generation human immunodeficiency virus screening assays. J. Clin. Microbiol. 36:2235-2239.
102. Weber, B., L. Gurtler, R. Thorstensson, U. Michl, A. Muhlbacher, P. Burgisser, R. Villaescusa, A. Eiras, C. Gabriel, H. Stekel, S. Tanprasert, S. Oota, M. J. Silvestre, C. Marques, M. Ladeira, H. Rabenau, A. Berger, U. Schmitt, and W. Melchior. 2002. Multicenter evaluation of a new automated fourth-generation human immunodeficiency virus screening assay with a sensitive antigen detection module and high specificity. J. Clin. Microbiol. 40:1938-1946.
103. Weber, B., T. Meier, and G. Enders. 2002. Fourth generation human immunodeficiency virus (HIV) screening assays with an improved sensitivity for p24 antigen close the second diagnostic window in primary HIV infection. J. Clin. Virol. 25:357-359.
104. Westblom, T. U., R. B. Belshe, G. J. Gorse, E. L. Anderson, C. F. Berry, et al. 1990. Characteristics of a population volunteering for human immunodeficiency virus immunization. Int. J. STD AIDS 1:126-128.
105. Willman, J. H., H. R. Hill, T. B. Martins, T. D. Jaskowski, E. R. Ashwood, and C. M. Litwin. 2001. Multiplex analysis of heterophil antibodies in patients with indeterminate HIV immunoassay results. Am. J. Clin. Pathol. 115:764-769.
106. World Health Organization. 1990. Proposed WHO criteria for interpreting results from Western blot assays for HIV-1, HIV-2, and HTLV-I/HTLV-II. Wkly. Epidemiol. Rec. 37:281-283.
107. World Health Organization. 2004. Guidelines for HIV Diagnosis and monitoring of antiretroviral therapy. World Health Organization, New Delhi, India.